COVID‐19(4) SARS‐CoV‐2(3) SARS‐CoV‐2(3) Vaccine(3) acute respiratory syndrome(3) effective(3) COVID(3) coronavirus(3) immunogenic(2) RBD(2) Safe(2) outcome(2) COVID‐19(2) nanoparticle(2) receptor‐binding domain(2) receptor‐binding domain(2) pandemic(2) diagnostic(2) Protein(2) T‐cell response(1) approvals(1) artificial intelligence(1) respiratory tract infection(1) facilitate(1) the spike protein(1) in vitro(1) Patient(1) Neutralizing antibodies(1) Antibody detection(1) mice(1)